性别与年龄对骨转移再程放疗无差异:SC.20随机试验二次分析
该研究为NCIC CTG SC.20随机试验的二次分析,纳入847例接受再程放疗的骨转移患者,评估性别与年龄对疼痛及患者报告结局的影响。结果显示所有亚组疼痛缓解获益相似,仅在基线症状、镇痛药使用及部分生活质量条目上存在差异,总体生存、放疗反应及C30评分无显著性别或年龄差异。
要点
- 骨转移再程放疗的疼痛缓解获益不受性别或年龄影响。
- 女性及年轻患者报告情绪与生活乐趣改善更明显。
- 应不论性别与年龄为骨转移患者提供姑息再程放疗。
核心结论
- 所有患者组均观察到相似的疼痛缓解获益,骨转移患者应不论性别或年龄接受姑息再程放疗。
研究设计与样本
- 加拿大国家癌症研究所临床试验组SC.20随机试验的二次分析,共分析847例接受再程放疗的骨转移患者。
主要发现
- 基线时男性呼吸困难更多、疼痛更轻,老年患者镇痛药消耗更少。
- 放疗后更多女性在BPI中报告情绪和生活乐趣有临床显著改善,年轻患者生活乐趣改善也更好。
- 总体生存、放疗反应及2个月时C30评分无显著性别或年龄差异。
关键数值与推荐
- 放疗反应采用国际骨转移共识终点定义评估。
- 患者再程放疗前及放疗后2个月完成简明疼痛评估量表(BPI)和欧洲癌症研究与治疗组织生活质量问卷核心30(C30)。
临床怎么用
- 临床决策不应因性别或年龄限制骨转移患者的姑息再程放疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Patient's gender and age may influence physicians in prescribing palliative radiotherapy. The purpose of this secondary analysis of the National Cancer Institute of Canada Clinical Trials Group Symptom Control Trial SC.20 was to explore the gender and age differences in pain and patient reported outcomes in cancer patients with bone metastases undergoing re-irradiation. MATERIALS AND METHODS: Response to radiation was evaluated using the International Bone Metastases Consensus Endpoint Definitions. Patients completed the Brief Pain Inventory (BPI) and European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (C30) before and 2 months after re-irradiation. RESULTS: A total of 847 patients were analyzed. At baseline, men had more dyspnea, and mild pain. Older patients consumed less analgesic. More women reported clinically significant improvement in mood and enjoyment of life in the BPI after radiation. Similarly, younger patients reported better improvement in enjoyment of life. There were no significant gender or age differences in overall survival, response to radiation, or in C30 scores at 2 months. CONCLUSION: Similar benefit in terms of pain relief was observed across all patient groups. Cancer patients with bone metastases should be offered palliative re-irradiation irrespective of gender or age. TRIAL REGISTRATION: NCT00080912; https://clinicaltrials.gov/ct2/show/NCT00080912.
引用
- Chow R, Ding K, Ganesh V, et al. Gender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trial. Radiother Oncol. 2017. PMID: 29102263. doi:10.1016/j.radonc.2017.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。